Literature DB >> 15582408

Syntheses of 2,4,6-trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors.

Sanjay Babu Katiyar1, Iti Bansal, J K Saxena, P M S Chauhan.   

Abstract

A series of 21 compounds of trisubstituted pyrimidine derivatives have been synthesized and evaluated for their in vitro topoisomerase II inhibitory activity against filarial parasite Setaria cervi. Out of these, seven compounds (8, 11-14, 25 and 28) have shown 60-80% inhibition at 40 and 20 microg/mL concentration. Five compounds (12, 13, 14, 25 and 28) exhibited 70-80% inhibition at 10 microg/mL concentration and three compounds (13, 14 and 28) have shown 40-60% inhibition at 5 microg/mL concentration. All the above mentioned compounds have shown better topo II inhibitory activity than standard antifilarial drug (DEC) and enzyme topo II inhibitors (Novobiocin, Nalidixic acid).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15582408     DOI: 10.1016/j.bmcl.2004.10.046

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  O(2)-dependent efficacy of novel piperidine- and piperazine-based chalcones against the human parasite Giardia intestinalis.

Authors:  Vijay Bahadur; Daniela Mastronicola; Hemandra Kumar Tiwari; Yogesh Kumar; Micol Falabella; Leopoldo Paolo Pucillo; Paolo Sarti; Alessandro Giuffrè; Brajendra Kumar Singh
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

2.  Synthesis, biological evaluation and docking studies of 1,2,4-oxadiazole linked 5-fluorouracil derivatives as anticancer agents.

Authors:  Ravi Kumar Bommera; Shashikala Kethireddy; Rajeshwar Reddy Govindapur; Laxminarayana Eppakayala
Journal:  BMC Chem       Date:  2021-05-04

Review 3.  Therapeutic potential of heterocyclic pyrimidine scaffolds.

Authors:  Sanjiv Kumar; Balasubramanian Narasimhan
Journal:  Chem Cent J       Date:  2018-04-04       Impact factor: 4.215

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.